- Home
- FRT vs LEGN Comparison
FRT vs LEGN Comparison
Compare FRT & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRT
- LEGN
- Stock Information
- Founded
- FRT 1962
- LEGN 2014
- Country
- FRT United States
- LEGN United States
- Employees
- FRT N/A
- LEGN N/A
- Industry
- FRT Real Estate Investment Trusts
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- FRT Real Estate
- LEGN Health Care
- Exchange
- FRT Nasdaq
- LEGN Nasdaq
- Market Cap
- FRT 8.1B
- LEGN 5.4B
- IPO Year
- FRT N/A
- LEGN 2020
- Fundamental
- Price
- FRT $93.03
- LEGN $39.59
- Analyst Decision
- FRT Buy
- LEGN Strong Buy
- Analyst Count
- FRT 14
- LEGN 12
- Target Price
- FRT $113.86
- LEGN $73.91
- AVG Volume (30 Days)
- FRT 703.2K
- LEGN 1.5M
- Earning Date
- FRT 08-06-2025
- LEGN 08-08-2025
- Dividend Yield
- FRT 4.73%
- LEGN N/A
- EPS Growth
- FRT 23.89
- LEGN N/A
- EPS
- FRT 3.47
- LEGN N/A
- Revenue
- FRT $1,223,588,000.00
- LEGN $728,303,000.00
- Revenue This Year
- FRT $5.09
- LEGN $65.33
- Revenue Next Year
- FRT $5.13
- LEGN $54.68
- P/E Ratio
- FRT $26.79
- LEGN N/A
- Revenue Growth
- FRT 6.05
- LEGN 112.46
- 52 Week Low
- FRT $80.65
- LEGN $27.34
- 52 Week High
- FRT $118.34
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- FRT 40.42
- LEGN 68.12
- Support Level
- FRT $93.75
- LEGN $38.86
- Resistance Level
- FRT $95.32
- LEGN $40.78
- Average True Range (ATR)
- FRT 1.62
- LEGN 1.52
- MACD
- FRT -0.12
- LEGN 0.33
- Stochastic Oscillator
- FRT 10.53
- LEGN 85.77
About FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.